HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intravenous infusion of ulinastatin attenuates acute kidney injury after cold ischemia/reperfusion.

AbstractBACKGROUND:
Administration of ulinastatin was proved to protect many organs from ischemia/reperfusion (I/R) induced injury, yet its protective effects on renal I/R injury under cold condition and mechanism still remain unclear.
AIMS:
In the present study, the protective effects of ulinastatin on renal cold I/R injury as well as its mechanism were investigated.
METHODS AND RESULTS:
Renal cold I/R model was constructed via cross-clamping of left renal artery and vein at 4 °C. The ulinastatin was administrated and multi-methods were performed to evaluate the protective effects. The results showed that ulinastatin could mitigate the renal cold I/R injury. In addition, the attenuated kidney cold I/R injury by ulinastatin was also accompanied with its regulating capability of the microenvironment, such as decreased acute inflammatory response, oxidative stress damage and apoptosis, as well as attenuation of vasculature levels decrease, as evidence by reduced TNF-α, IL-6 mRNA expression, MDA levels and apoptosis, higher levels of SOD activity and CD31/α-SMA expression.
CONCLUSION:
The present study suggested that ulinastatin might be clinically useful in reducing preservation injury induced by cold I/R during renal transplantation surgery.
AuthorsYunpeng Wang, Cheng Peng, Zheng Zhang, Jing Shi, Yingli Lin, Liangyou Gu, Xin Ma, Hongzhao Li
JournalInternational urology and nephrology (Int Urol Nephrol) Vol. 51 Issue 10 Pg. 1873-1881 (Oct 2019) ISSN: 1573-2584 [Electronic] Netherlands
PMID31332701 (Publication Type: Journal Article)
Chemical References
  • Glycoproteins
  • urinastatin
Topics
  • Acute Kidney Injury (etiology, prevention & control)
  • Animals
  • Cold Ischemia (adverse effects)
  • Glycoproteins (administration & dosage)
  • Infusions, Intravenous
  • Male
  • Rats, Sprague-Dawley
  • Reperfusion (adverse effects)
  • Reperfusion Injury (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: